Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
| Cat. No. | Species | Product Description | Structure | Purity | Feature |
|---|---|---|---|---|---|
| VEC-M82E3 | Mouse | Biotinylated Mouse VEGF-C Protein, His,Avitag™ (MALS verified) |  |
|
|
| VEC-C82E4 | Cynomolgus | Biotinylated Cynomolgus VEGF-C Protein, His,Avitag™ (MALS verified) |  |
|
|
| VEC-H52H3 | Human | Human VEGF-C / Flt4-L Protein, His Tag (MALS verified) |  |
|
|
Human VEGF-C, His Tag (Cat. No. VEC-H4225) captured on CM5 Chip via anti-His antibody can bind Human VEGF R3, Fc Tag (Cat. No. FL4-H5251) with an affinity constant of 41.1 pM as determined in SPR assay (Biacore T200) (Routinely tested).
The purity of Human VEGF-C, His Tag (Cat. No. VEC-H4225) is more than 95% and the molecular weight of this protein is around 32-42 kDa verified by SEC-MALS.
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| VEGF-C gene therapy (Herantis Pharma) | Ad-VEGF-C; LX-1101 | Herantis Pharma | Details | ||
| Sozinibercept | OPT-302; VGX-300 | Phase 3 Clinical | Orphan Europe Sarl | Neovascularization, Pathologic; Retinal Diseases; Diabetic macular oedema; Retinal Degeneration; Eye Diseases; Macular Degeneration | Details |
| IBI-333 | IBI-333 | Phase 1 Clinical | Innovent Biologics (Usa), Inc | Wet Macular Degeneration; Macular Degeneration | Details |
This web search service is supported by Google Inc.
A-Z
